Kalium Chloratum Kabi

Potassium chloride, the active ingredient in Kalium Chloratum Kabi, is an electrolyte supplement presented as an injection solution for intravenous use. It restores potassium levels in patients with hypokalemia and supports cellular function during intravenous potassium replacement therapy.

GNH USA supplies Kalium Chloratum Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product complies with European Union quality standards and is manufactured under GMP conditions, ensuring consistent potency and safety for patients.

Kalium Chloratum Kabi, a potassium chloride injection, is used in electrolyte management to correct low serum potassium. - Hypokalemia: restores serum potassium to the normal range. - Intravenous potassium supplementation: provides essential potassium for patients unable to take oral preparations. - Peri‑operative care: maintains electrolyte balance in surgical patients at risk of potassium loss.

Intravenous potassium chloride can be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Phlebitis: inflammation of the vein used for infusion. - Nausea: transient feeling of queasiness.

Serious or Rare Side Effects: - Severe hyperkalemia: potentially life‑threatening elevation of serum potassium. - Cardiac arrhythmias: abnormal heart rhythms including ventricular fibrillation. - Tissue necrosis: injury from extravasation of the solution into surrounding tissue.

When using Kalium Chloratum Kabi, clinicians should observe several safety measures. - Assess serum potassium: verify level before infusion. - Correct electrolyte imbalances: ensure adequate magnesium and calcium. - Infuse slowly: limit rate to ≤10 mEq per hour to reduce cardiac risk. - Monitor cardiac rhythm: continuous ECG monitoring during administration. - Avoid peripheral veins with irritant risk: use a central line for high‑concentration infusions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride may interact with several drug classes, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - ACE inhibitors: may potentiate hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of severe hyperkalemia. - NSAIDs: can reduce renal potassium excretion, raising serum levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hyperkalemia. - Digoxin: elevated potassium can increase digoxin toxicity. - Renal replacement therapy: adjust dosing based on clearance.